Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Nephro Care India Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹90
Per ShareLot Size
1600 Shares
Minimum Investment
₹1,44,000
Issue Size
₹41.26 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
84.02%
Promoter Holding (Post-Issue)
60.66%
Issue Type
Book Building - SME
ISIN
INE0SUN01013
Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure.
CKD is a severe public health issue in India. As per government estimates, nearly 2,20,000 patients develop end-stage renal disease (ESRD) annually in India, leading to an additional annual dialysis demand of 34 million treatment sessions. Unfortunately, in India, renal insufficiency treatment focuses more on curative nephrology rather than preventive and holistic solutions. Kidney disease is a significant public health concern in India, with high morbidity and mortality rates. The Million Death Study estimated a 50% increase in deaths due to chronic kidney disease (CKD) between 2001-2003 and 2010-2013. Several surveys have shown a high population prevalence of CKD. As many as one out of every five adults in high-prevalence areas has CKD. Similarly, acute kidney injury is common and carries a high mortality, especially because treatment is frequently delayed. However, the National Programme for Prevention & Control of Cancer, Diabetes, Cardio-vascular diseases and Stroke (NPCDCS), the flagship NCD prevention programme in India, does not cover kidney care.
Revenue, profit after tax and total assets for the last reported financial year.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Public issue of 45,84,000 equity shares of face value of Rs. 10 each ("Equity Shares") of Nepho Care India Limited (the "Company" or the "Issuer") for cash at a price of Rs. 90 per equity (the "Issue Price") aggregating to Rs. 41.26 crores ("The Issue") comprising of a fresh issue of 45,84,000 equity shares aggregating to Rs. 41.26 crores (the "Fresh Issue") of which 2,25,600 equity shares aggregating to Rs. 2.03 crores will be reserved for subscription by eligible employees of the company (the "Employees Reservation Portion") and 2,30,400 equity shares aggregating to Rs. 2.07 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the employees reservation portion and the market maker reservation portion i.e. net issue of 41,28,000 equity shares aggregating to Rs. 37.15 crores (the "Net Issue"). The issue and the net issue will constitute 27.80% and 25.04 % respectively of the post issue paid up equity share capital of the company. The Offer Price is Rs. 90 per equity share of face value of Rs. 10/- each. The issue price is 9.00 times of the face value of the equity shares. Bid can be made for minimum of 1600 equity shares and the multiples of 1600 equity shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Our Company was originally incorporated on July 08, 2014 as a Private Limited Company as "Nephro Care India Private Limited" under the provisions of the Companies Act, 2013 with the Registrar of Companies, West Bengal. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our Shareholders at an extraordinary general meeting held on December 26, 2023 and consequently the name of our Company was changed to `Nephro Care India Limited' and a fresh certificate of incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U85100WB2014PLC202429.
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY26.